tiprankstipranks
Mochida Pharmaceutical Co., Ltd. (JP:4534)
:4534
Japanese Market
4534
Mochida Pharmaceutical Co., Ltd.
RESEARCH TOOLSreports
Want to see JP:4534 full AI Analyst Report?

Mochida Pharmaceutical Co., Ltd. (4534) Ratios

1 Followers

Mochida Pharmaceutical Co., Ltd. Ratios

JP:4534's free cash flow for Q1 2025 was ¥0.51. For the 2025 fiscal year, JP:4534's free cash flow was decreased by ¥ and operating cash flow was ¥0.10. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 4.29 4.29 4.81 4.47 4.31
Quick Ratio
 2.99 2.99 3.47 3.31 3.41
Cash Ratio
 1.01 1.01 1.81 1.28 1.72
Solvency Ratio
 0.26 0.26 0.26 0.24 0.29
Operating Cash Flow Ratio
 0.00 -0.27 0.38 -0.29 0.27
Short-Term Operating Cash Flow Coverage
 0.00 0.00 359.77 -287.69 608.08
Net Current Asset Value
¥ 76.63B¥ 76.63B¥ 86.80B¥ 85.83B¥ 85.32B
Leverage Ratios
Debt-to-Assets Ratio
 0.05 0.05 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 0.07 0.07 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
 0.07 0.07 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.07 0.07 0.00 0.00 0.00
Financial Leverage Ratio
 1.30 1.30 1.25 1.24 1.25
Debt Service Coverage Ratio
 136.94 136.94 300.00 262.75 776.67
Interest Coverage Ratio
 140.94 140.94 2.71K 2.90K 0.00
Debt to Market Cap
 0.08 0.08 <0.01 <0.01 <0.01
Interest Debt Per Share
 284.12 284.12 9.73 10.34 5.11
Net Debt to EBITDA
 -1.38 -1.38 -4.05 -3.67 -4.00
Profitability Margins
Gross Profit Margin
48.11%48.11%51.15%50.61%53.37%
EBIT Margin
8.68%8.68%7.73%5.99%8.76%
EBITDA Margin
11.22%11.22%10.52%8.72%11.35%
Operating Profit Margin
8.68%8.68%7.73%5.64%8.24%
Pretax Profit Margin
9.55%9.55%7.66%5.99%8.76%
Net Profit Margin
6.76%6.76%5.41%4.42%6.44%
Continuous Operations Profit Margin
6.76%6.76%5.41%4.42%6.44%
Net Income Per EBT
70.75%70.75%70.60%73.81%73.52%
EBT Per EBIT
110.08%110.08%99.08%106.17%106.31%
Return on Assets (ROA)
4.33%4.33%3.48%2.86%4.19%
Return on Equity (ROE)
5.81%5.63%4.35%3.55%5.24%
Return on Capital Employed (ROCE)
6.55%6.55%5.86%4.37%6.47%
Return on Invested Capital (ROIC)
4.63%4.63%4.14%3.23%4.75%
Return on Tangible Assets
4.35%4.35%3.50%2.88%4.21%
Earnings Yield
6.10%6.44%5.04%3.96%5.36%
Efficiency Ratios
Receivables Turnover
 3.21 3.21 3.33 2.95 3.71
Payables Turnover
 5.63 5.63 5.93 4.17 5.32
Inventory Turnover
 1.68 1.68 1.54 1.68 1.97
Fixed Asset Turnover
 7.17 7.17 6.60 6.48 6.86
Asset Turnover
 0.64 0.64 0.64 0.65 0.65
Working Capital Turnover Ratio
 1.29 1.26 1.13 1.14 1.14
Cash Conversion Cycle
 266.27 266.27 284.78 253.58 214.71
Days of Sales Outstanding
 113.85 113.85 109.74 123.59 98.29
Days of Inventory Outstanding
 217.24 217.24 236.57 217.48 185.01
Days of Payables Outstanding
 64.81 64.81 61.53 87.50 68.59
Operating Cycle
 331.08 331.08 346.31 341.08 283.30
Cash Flow Ratios
Operating Cash Flow Per Share
 0.00 -207.33 263.86 -208.57 196.37
Free Cash Flow Per Share
 0.00 -283.36 202.93 -272.59 138.08
CapEx Per Share
 0.00 76.02 60.93 64.02 58.29
Free Cash Flow to Operating Cash Flow
 0.00 1.37 0.77 1.31 0.70
Dividend Paid and CapEx Coverage Ratio
 0.00 -1.33 1.87 -1.44 1.32
Capital Expenditure Coverage Ratio
 0.00 -2.73 4.33 -3.26 3.37
Operating Cash Flow Coverage Ratio
 0.00 -0.73 27.35 -20.27 38.41
Operating Cash Flow to Sales Ratio
 0.00 -0.06 0.09 -0.07 0.07
Free Cash Flow Yield
0.00%-8.19%6.38%-8.52%4.13%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 15.45 15.52 19.83 25.24 18.67
Price-to-Sales (P/S) Ratio
 1.04 1.05 1.07 1.12 1.20
Price-to-Book (P/B) Ratio
 0.87 0.87 0.86 0.90 0.98
Price-to-Free Cash Flow (P/FCF) Ratio
 0.00 -12.21 15.67 -11.74 24.19
Price-to-Operating Cash Flow Ratio
 0.00 -16.69 12.05 -15.34 17.01
Price-to-Earnings Growth (PEG) Ratio
 0.40 0.40 0.75 -0.87 -0.53
Price-to-Fair Value
 0.87 0.87 0.86 0.90 0.98
Enterprise Value Multiple
 7.93 7.97 6.14 9.12 6.60
Enterprise Value
 111.50B 104.59B 67.92B 81.84B 77.29B
EV to EBITDA
 8.49 7.97 6.14 9.12 6.60
EV to Sales
 0.95 0.89 0.65 0.80 0.75
EV to Free Cash Flow
 0.00 -10.41 9.44 -8.37 15.06
EV to Operating Cash Flow
 0.00 -14.23 7.26 -10.94 10.59
Tangible Book Value Per Share
 3.96K 3.96K 3.66K 3.55K 3.39K
Shareholders’ Equity Per Share
 3.96K 3.96K 3.69K 3.57K 3.41K
Tax and Other Ratios
Effective Tax Rate
 0.29 0.29 0.29 0.26 0.26
Revenue Per Share
 3.30K 3.30K 2.97K 2.87K 2.78K
Net Income Per Share
 222.93 222.93 160.36 126.79 178.93
Tax Burden
 0.71 0.71 0.71 0.74 0.74
Interest Burden
 1.10 1.10 0.99 1.00 1.00
Research & Development to Revenue
 0.08 0.00 0.11 0.12 0.13
SG&A to Revenue
 0.32 0.39 0.32 0.45 0.45
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.00 -0.93 1.65 -1.65 0.81
Currency in JPY